Author:
Michna H.,Nishino Y.,Schneider M.R.,Louton T.,El Etreby M.F.
Subject
Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. First clinical trial on the use of the antiprogestin RU 486 in advanced breast cancer;Maudelonde,1987
2. Antiprogestins, a new form of endocrine therapy for human breast cancer;Klijn;Cancer Res.,1989
3. Mifepristone in treatment of experimental breast cancer in rats;Bakker,1987
4. Antitumor activity of the progesterone antagonists ZK 98.299 and RU 486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and MNU-induced mammary tumor model of the rat;Schneider;Eur. J. Cancer Clin. Oncol.,1989
5. Antitumor activity of the antiprogesterones ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies;Michna;Breast Cancer Res. Treat.,1989
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mifepristone Treatment in Pregnant Murine Model Induced Mammary Gland Dysplasia and Postpartum Hypogalactia;Frontiers in Cell and Developmental Biology;2020-02-21
2. Ovarian Hormones;Drug Discovery and Evaluation: Pharmacological Assays;2016
3. Ovarian Hormones;Drug Discovery and Evaluation: Pharmacological Assays;2015
4. Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors;Current Cancer Therapy Reviews;2010-02-01
5. Endocrinology;Drug Discovery and Evaluation;2007